Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Equity Average (2022 - 2025)

Historic Equity Average for HeartSciences (HSCS) over the last 4 years, with Q4 2025 value amounting to $3.7 million.

  • HeartSciences' Equity Average fell 2640.12% to $3.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $3.7 million, marking a year-over-year decrease of 2640.12%. This contributed to the annual value of $3.8 million for FY2025, which is 33.63% down from last year.
  • Latest data reveals that HeartSciences reported Equity Average of $3.7 million as of Q4 2025, which was down 2640.12% from $1.7 million recorded in Q3 2025.
  • HeartSciences' 5-year Equity Average high stood at $8.0 million for Q2 2024, and its period low was -$1.6 million during Q3 2022.
  • Over the past 4 years, HeartSciences' median Equity Average value was $1.8 million (recorded in 2022), while the average stood at $2.3 million.
  • Per our database at Business Quant, HeartSciences' Equity Average tumbled by 15447.05% in 2023 and then skyrocketed by 5841159.57% in 2024.
  • Over the past 4 years, HeartSciences' Equity Average (Quarter) stood at $2.0 million in 2022, then tumbled by 154.47% to -$1.1 million in 2023, then surged by 558.69% to $5.0 million in 2024, then fell by 26.4% to $3.7 million in 2025.
  • Its last three reported values are $3.7 million in Q4 2025, $1.7 million for Q3 2025, and $995930.0 during Q2 2025.